$3.5M gene therapy for hemophilia gets FDA approval

Indonesia Berita Berita

$3.5M gene therapy for hemophilia gets FDA approval
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 cleveland19news
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 68%

“Today’s approval provides a new treatment option for patients with hemophilia B and represents important progress in the development of innovative therapies.”

The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, patients receive frequent, expensive IVs of a protein that helps blood clot and prevent bleeding.

Like most medicines in the U.S., most of the cost of the new treatment will be paid by insurers — not patients — including private plans and government programs. “Today’s approval provides a new treatment option for patients with hemophilia B and represents important progress in the development of innovative therapies,” said the FDA’s Dr. Peter Marks.

Hemophilia almost always strikes males and is caused by mutations in the gene for a protein needed for blood clotting. Small cuts or bruises can be life-threatening, and many people need treatments once or more a week to prevent serious bleeding. Left untreated, the condition can cause bleeding that seeps into joints and internal organs, including the brain.Hemophilia B affects about 1 in 40,000 people and accounts for roughly 15% of those with the disease, according to the FDA.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

cleveland19news /  🏆 70. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA warns against consuming raw oysters distributed to 13 states after reported illnessesFDA warns against consuming raw oysters distributed to 13 states after reported illnessesSapoviruses cause a sporadic gastroenteritis and the most common symptoms are diarrhea, vomiting, nausea and stomach pain, according to the FDA.
Baca lebih lajut »

FDA warns against consuming raw oysters distributed to 13 states after reported illnessesFDA warns against consuming raw oysters distributed to 13 states after reported illnessesSapoviruses cause a sporadic gastroenteritis and the most common symptoms are diarrhea, vomiting, nausea and stomach pain, according to the FDA.
Baca lebih lajut »

FDA warns against consuming raw oysters distributed to 13 states after reported illnessesFDA warns against consuming raw oysters distributed to 13 states after reported illnessesSapoviruses cause a sporadic gastroenteritis and the most common symptoms are diarrhea, vomiting, nausea and stomach pain, according to the FDA.
Baca lebih lajut »

FDA warns against consuming raw oysters distributed to 13 states after reported illnessesFDA warns against consuming raw oysters distributed to 13 states after reported illnessesSapoviruses cause a sporadic gastroenteritis and the most common symptoms are diarrhea, vomiting, nausea and stomach pain, according to the FDA.
Baca lebih lajut »

FDA warns against consuming raw oysters distributed to 13 states after reported illnessesFDA warns against consuming raw oysters distributed to 13 states after reported illnessesSapoviruses cause a sporadic gastroenteritis and the most common symptoms are diarrhea, vomiting, nausea and stomach pain, according to the FDA.
Baca lebih lajut »



Render Time: 2025-03-06 17:38:33